Valeria Razmilic

Dr. Valeria Razmilic

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 October 2022 in Molecules
Verified
Journal Article
Open access
PDF file
RARishi Vachaspathy Astakala
Rishi Vachaspathy Astakala
Gagan PreetGagan Preet
Gagan Preet
BMBruce Milne
Bruce Milne
Julius TibyangyeJulius Tibyangye
Julius Tibyangye
VRValeria Razmilic
Valeria Razmilic
MJMarcel Jaspars
Marcel Jaspars
Bacteria belonging to the phylum Actinobacteria are a very good source of antibiotics, and indeed dominate the current clinical antibiotic space. This paper reports Mutactimycin AP, a new compound belonging to an anthracycline-type family of antibiotics, isolated from a Saccharothrix sp. This actinobacterial strain was isolated from the rhizosphere of lupine plants growing in the extreme hyper-arid Atacama Desert. Structural characterization was carried out using electrospray ionization-mass spectrometry (ESI-MS) and NMR spectroscopy in combination with molecular modelling. The compound was tested against the ESKAPE pathogens, where it showed activity against MRSA and five strains associated with bovine mastitis, where it showed activity against Enterococcus pseudoavium and Staphylycoccus Aureus subsp. Aureus.

16 September 2025 in Biotechnology and Bioengineering
Verified
Journal Article
Closed access
ARAnett Rubio
Anett Rubio
VRValeria Razmilic
Valeria Razmilic
SBStephanie Brain‐Isasi
Stephanie Brain‐Isasi
BABarbara Andrews
Barbara Andrews
JAJuan A. Asenjo
Juan A. Asenjo

29 December 2024 in Biotechnology and Bioengineering
Verified
Journal Article
Closed access
VRValeria Razmilic
Valeria Razmilic
JAJuan A. Asenjo
Juan A. Asenjo
IMIrene Martínez
Irene Martínez

Verified
Journal Article
Open access
PDF file
CGCarolina González
Carolina González
SRSebastian Rodriguez
Sebastian Rodriguez
JRJosé Pablo Reyes-Godoy
José Pablo Reyes-Godoy
VRValeria Razmilic
Valeria Razmilic
IMIrene Martínez
Irene Martínez
The Atacama Desert is emerging as an unexpected source of microbial life and, thus, a source of bioactive compounds and novel enzymes. Baeyer–Villiger monooxygenases (BVMOs), a subclass of flavin-dependent monooxygenases (FPMOs), have gained attention as promising biocatalysts for the biosynthesis of industrially relevant molecules for a wide range of applications, such as pharmaceuticals and polymers, among others. BVMOs catalyze the oxidation of ketones and cyclic ketones to esters and lactones, respectively, by using molecular oxygen and NAD(P)H. BVMOs may also catalyze heteroatoms oxidation including sulfoxidations and N-oxidations. This work aims to search for novel BVMOs in the genomes of new bacterial strains isolated from the Atacama Desert. Bioinformatic analysis led to the identification of 10 putative BVMOs, where the monooxygenase named MO-G35A was selected. Genome context showed, downstream of the MO-G35A, a gene encoding for an enzyme from the short-chain dehydrogenase/reductase family, suggesting a closer redox loop between both enzymes. MO-G35A was successfully expressed in three Escherichia coli expression systems, where higher yields were achieved using the E. coli Shuffle T7 as host, suggesting that correct disulfide bond formation is necessary for correct folding. Enzyme characterization showed that it operates optimally at 35–38 °C, exhibiting a Km of 0.06 mM and a kcat of 0.15 s−1 for bicyclo [3.2.0] hept-2-en-6-one (BHC). Furthermore, the study revealed high stability in the presence of organic solvents, making it suitable for applications in various industrial processes, especially when the substrates have poor solubility in aqueous solutions. These results highlight the robustness and adaptability of enzymes in extreme environments, making them valuable candidates for biotechnological applications.